Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Physics and Imaging in Radiation Oncology|October 9, 2024
Autodelineation methods in a simulated fully automated proton therapy workflow for esophageal cancerPieter Populaire, Beatrice Marini, Kenneth Poels, et al.
Clinical & Experimental Metastasis|February 22, 2022
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selectionCiro Franzese, Matteo Perrino, Marco Antonio Marzo, et al.
Cancers|February 13, 2026
The Role of Dosimetric Parameters in Radiation Pneumonitis: A Functional Approach in Adjuvant Treatment of Malignant Pleural MesotheliomaLuca Dominici, Davide Franceschini, Mauro Loi, et al.
Diseases (Basel, Switzerland)|July 26, 2024
STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung LesionsDavide Franceschini, Mauro Loi, Antonio Marco Marzo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2022
Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 StudyPierina Navarria, Davide Baldaccini, Elena Clerici, et al.
Radiation Oncology (London, England)|August 26, 2022
Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patientsDavide Franceschini, Luca Cozzi, Antonella Fogliata, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 8, 2025
Stereotactic body radiation therapy for the re-irradiation of local relapse from prostate cancer: results in terms of outcomes and toxicityCiro Franzese, Raffaella Lucchini, Marco Badalamenti, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II TrialDavide Franceschini, Tiziana Comito, Anna Di Gallo, et al.
Journal of Cancer Research and Clinical Oncology|June 6, 2023
Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)Ciro Franzese, Veronica Vernier, Davide Franceschini, et al.
Cancers|March 11, 2023
Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective StudyPierina Navarria, Federico Pessina, Giuseppe Minniti, et al.
Pageof 2